Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
STM-279 (elapegademase) in patients with adenosine deaminase deficiency
jRCT2080223149Phase 3Completed
- Sponsor
- Teijin Pharma
- Start
- Mar 2016
- Modality
- Replacement Enzymes → Therapeutic Enzymes → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of elapegademase in adenosine deaminase deficiency, sponsored by Teijin Pharma. Started Mar 2016; status: completed.
02
Drugs
elapegademase
03
Conditions
adenosine deaminase deficiency
Beyond the preview
Go deeper on jRCT2080223149.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080223149.